| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |